Molecular Mechanism of Action
Thiopental sodium exerts its pharmacological effects by binding to specific barbiturate binding sites located on the GABA_A receptor complex.
Central nervous system depression occurs through several sequential steps:
- The drug alters the spatial conformation of the GABA_A receptor.
- It significantly increases receptor sensitivity to the endogenous inhibitory neurotransmitter, gamma-aminobutyric acid (GABA).
- Prolonged activation and opening of chloride channels occur.
- A massive influx of chloride ions ($Cl^-$) into the neuron is facilitated.
- Cellular membrane hyperpolarization ensues, rendering the generation of action potentials impossible (profound inhibition).
Additionally, the drug exhibits direct GABA-mimetic activity, meaning it can activate the receptor complex to a certain extent even in the absence of endogenous GABA.
Pharmacokinetics and the Redistribution Phenomenon
The drug is characterized by extremely high anesthetic potency. Its high lipophilicity allows molecules to rapidly cross the blood-brain barrier and enter brain tissue.
- Onset of Effect: Following intravenous injection, anesthesia develops within 1 minute. A crucial clinical feature is the complete absence of an excitation phase.
- Duration: The effect of a single dose is short-lived, lasting only 15–25 minutes.
Rapid patient awakening is due to the redistribution phenomenon. The decrease in drug concentration in the central nervous system occurs not primarily through hepatic metabolism, but via the movement of molecules into adipose tissue where they accumulate.
Meanwhile, hepatic metabolism proceeds much slower than redistribution: only 12–16% of the drug is metabolized per hour. This is why patients experience prolonged drowsiness after regaining consciousness—known as postoperative sleep, caused by the slow release of unchanged thiopental from fat stores back into the systemic circulation.
Clinical Uses and Safety Guidelines
The drug is supplied as a powder in vials, which must be reconstituted immediately prior to use.
Main Indications:
- Induction of anesthesia — the most common application, providing rapid and smooth entry into anesthesia without motor excitation.
- Short surgical procedures.
- Emergency management of status epilepticus and severe psychomotor agitation.
Administration Features and Safety:
- Chemical Incompatibility: The reconstituted solution is strongly alkaline (pH approximately 10). Mixing it with any acidic solutions causes immediate precipitation of barbituric acid.
- Rate of Administration: Injections must be administered strictly slowly. Rapid intravenous injection carries a critical risk of profound respiratory and vasomotor center depression, leading to apnea and vascular collapse.
- Contraindications: The drug is strictly contraindicated in patients with severe hepatic or renal impairment. Such patients face a high risk of drug accumulation, unpredictable prolongation of action, and severe toxicity.